fcγr Search Results


90
Microm International GmbH anti-fcgammar antibody
Anti Fcgammar Antibody, supplied by Microm International GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/fc%CE%B3r/anti+fcgammar+antibody/us07790399-119-30-14
Average 90 stars, based on 1 article reviews
anti-fcgammar antibody - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

90
Becton Dickinson human fcγr-binding inhibitor
Human Fcγr Binding Inhibitor, supplied by Becton Dickinson, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/fc%CE%B3r/human+fc%CE%B3r+binding+inhibitor/pmc07358435-53-17-24
Average 90 stars, based on 1 article reviews
human fcγr-binding inhibitor - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

90
Unum Therapeutics fcγr-car-t cell therapy
Fcγr Car T Cell Therapy, supplied by Unum Therapeutics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/fc%CE%B3r/fc%CE%B3r+car+t+cell+therapy/10__1158_slash_1535___7163__mct___20___0385-118-0-12
Average 90 stars, based on 1 article reviews
fcγr-car-t cell therapy - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

90
Bioceros Inc rat igg2b anti-murine fcγr monospecific ab 2.4g2
Rat Igg2b Anti Murine Fcγr Monospecific Ab 2.4g2, supplied by Bioceros Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/fc%CE%B3r/rat+igg2b+anti+murine+fc%CE%B3r+monospecific+ab+2+4g2/us12030949-676-12-19
Average 90 stars, based on 1 article reviews
rat igg2b anti-murine fcγr monospecific ab 2.4g2 - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

90
BioExpress fcγr-blocking mab 2.4g2 antibody
Fcγr Blocking Mab 2.4g2 Antibody, supplied by BioExpress, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/fc%CE%B3r/fc%CE%B3r+blocking+mab+2+4g2+antibody/pmc03336769-43-52-55
Average 90 stars, based on 1 article reviews
fcγr-blocking mab 2.4g2 antibody - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

90
Abnova recombinant human fcγ receptor ia
The binding properties of the acid conformer to Protein A, antigen and <t>Fcγ</t> receptors. A, inhibition of the binding between the type II peptide and the acid conformer by Protein A. Acid-treated MRA (660 nm) was injected to the type II peptide (IMG4K6R)-immobilized sensor chip in the presence of several concentrations of Protein A (0-24 μm). At the time indicated by the arrow (450 s), the injection phase was stopped and the cells were washed with HBS buffer. B, antigen- and receptor-binding properties of the acid conformer trapped on the type II peptide-immobilized sensor chip. Acid-treated MRA (660 nm) was trapped on the sensor chip at 2200 RU. The antigen (human IL-6R) or <t>FcγR</t> (human FcγRIa, FcγRIIb, or FcγRIIIa) was subsequently injected at each concentration (times indicated by arrows). C, schematic diagram of human IgG. Acid treatment induces conformational changes on the Fc region but not on the Fabs or antigen binding region.
Recombinant Human Fcγ Receptor Ia, supplied by Abnova, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/fc%CE%B3r/recombinant+human+fc%CE%B3+receptor++fc%CE%B3r++iiia/pmc02665122-57-0-12
Average 90 stars, based on 1 article reviews
recombinant human fcγ receptor ia - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

90
Becton Dickinson anti-fcγr abs, 2.4g2
The binding properties of the acid conformer to Protein A, antigen and <t>Fcγ</t> receptors. A, inhibition of the binding between the type II peptide and the acid conformer by Protein A. Acid-treated MRA (660 nm) was injected to the type II peptide (IMG4K6R)-immobilized sensor chip in the presence of several concentrations of Protein A (0-24 μm). At the time indicated by the arrow (450 s), the injection phase was stopped and the cells were washed with HBS buffer. B, antigen- and receptor-binding properties of the acid conformer trapped on the type II peptide-immobilized sensor chip. Acid-treated MRA (660 nm) was trapped on the sensor chip at 2200 RU. The antigen (human IL-6R) or <t>FcγR</t> (human FcγRIa, FcγRIIb, or FcγRIIIa) was subsequently injected at each concentration (times indicated by arrows). C, schematic diagram of human IgG. Acid treatment induces conformational changes on the Fc region but not on the Fabs or antigen binding region.
Anti Fcγr Abs, 2.4g2, supplied by Becton Dickinson, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/fc%CE%B3r/anti+fc%CE%B3r+abs++2+4g2/pmc03074384-95-8-9
Average 90 stars, based on 1 article reviews
anti-fcγr abs, 2.4g2 - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

90
Genentech inc gst-tagged fcγr extracellular domains
The binding properties of the acid conformer to Protein A, antigen and <t>Fcγ</t> receptors. A, inhibition of the binding between the type II peptide and the acid conformer by Protein A. Acid-treated MRA (660 nm) was injected to the type II peptide (IMG4K6R)-immobilized sensor chip in the presence of several concentrations of Protein A (0-24 μm). At the time indicated by the arrow (450 s), the injection phase was stopped and the cells were washed with HBS buffer. B, antigen- and receptor-binding properties of the acid conformer trapped on the type II peptide-immobilized sensor chip. Acid-treated MRA (660 nm) was trapped on the sensor chip at 2200 RU. The antigen (human IL-6R) or <t>FcγR</t> (human FcγRIa, FcγRIIb, or FcγRIIIa) was subsequently injected at each concentration (times indicated by arrows). C, schematic diagram of human IgG. Acid treatment induces conformational changes on the Fc region but not on the Fabs or antigen binding region.
Gst Tagged Fcγr Extracellular Domains, supplied by Genentech inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/fc%CE%B3r/gst+tagged+fc%CE%B3r+extracellular+domains/pmc03896603-219-15-18
Average 90 stars, based on 1 article reviews
gst-tagged fcγr extracellular domains - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

90
Corning Life Sciences anti-fcγr monoclonal antibodies
The binding properties of the acid conformer to Protein A, antigen and <t>Fcγ</t> receptors. A, inhibition of the binding between the type II peptide and the acid conformer by Protein A. Acid-treated MRA (660 nm) was injected to the type II peptide (IMG4K6R)-immobilized sensor chip in the presence of several concentrations of Protein A (0-24 μm). At the time indicated by the arrow (450 s), the injection phase was stopped and the cells were washed with HBS buffer. B, antigen- and receptor-binding properties of the acid conformer trapped on the type II peptide-immobilized sensor chip. Acid-treated MRA (660 nm) was trapped on the sensor chip at 2200 RU. The antigen (human IL-6R) or <t>FcγR</t> (human FcγRIa, FcγRIIb, or FcγRIIIa) was subsequently injected at each concentration (times indicated by arrows). C, schematic diagram of human IgG. Acid treatment induces conformational changes on the Fc region but not on the Fabs or antigen binding region.
Anti Fcγr Monoclonal Antibodies, supplied by Corning Life Sciences, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/fc%CE%B3r/anti+fc%CE%B3r+monoclonal+antibodies/us08163289-26-11-43
Average 90 stars, based on 1 article reviews
anti-fcγr monoclonal antibodies - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

90
Regeneron inc mice bearing all human fcγr
The binding properties of the acid conformer to Protein A, antigen and <t>Fcγ</t> receptors. A, inhibition of the binding between the type II peptide and the acid conformer by Protein A. Acid-treated MRA (660 nm) was injected to the type II peptide (IMG4K6R)-immobilized sensor chip in the presence of several concentrations of Protein A (0-24 μm). At the time indicated by the arrow (450 s), the injection phase was stopped and the cells were washed with HBS buffer. B, antigen- and receptor-binding properties of the acid conformer trapped on the type II peptide-immobilized sensor chip. Acid-treated MRA (660 nm) was trapped on the sensor chip at 2200 RU. The antigen (human IL-6R) or <t>FcγR</t> (human FcγRIa, FcγRIIb, or FcγRIIIa) was subsequently injected at each concentration (times indicated by arrows). C, schematic diagram of human IgG. Acid treatment induces conformational changes on the Fc region but not on the Fabs or antigen binding region.
Mice Bearing All Human Fcγr, supplied by Regeneron inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/fc%CE%B3r/mice+bearing+all+human+fc%CE%B3r/pmc08753441-36-0-8
Average 90 stars, based on 1 article reviews
mice bearing all human fcγr - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

90
Becton Dickinson anti-mouse fcγr antibody
The binding properties of the acid conformer to Protein A, antigen and <t>Fcγ</t> receptors. A, inhibition of the binding between the type II peptide and the acid conformer by Protein A. Acid-treated MRA (660 nm) was injected to the type II peptide (IMG4K6R)-immobilized sensor chip in the presence of several concentrations of Protein A (0-24 μm). At the time indicated by the arrow (450 s), the injection phase was stopped and the cells were washed with HBS buffer. B, antigen- and receptor-binding properties of the acid conformer trapped on the type II peptide-immobilized sensor chip. Acid-treated MRA (660 nm) was trapped on the sensor chip at 2200 RU. The antigen (human IL-6R) or <t>FcγR</t> (human FcγRIa, FcγRIIb, or FcγRIIIa) was subsequently injected at each concentration (times indicated by arrows). C, schematic diagram of human IgG. Acid treatment induces conformational changes on the Fc region but not on the Fabs or antigen binding region.
Anti Mouse Fcγr Antibody, supplied by Becton Dickinson, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/fc%CE%B3r/anti+mouse+fc%CE%B3r+antibody/pmc02875372-84-10-16
Average 90 stars, based on 1 article reviews
anti-mouse fcγr antibody - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

90
Becton Dickinson fcγr-block clone 2.4g2
The binding properties of the acid conformer to Protein A, antigen and <t>Fcγ</t> receptors. A, inhibition of the binding between the type II peptide and the acid conformer by Protein A. Acid-treated MRA (660 nm) was injected to the type II peptide (IMG4K6R)-immobilized sensor chip in the presence of several concentrations of Protein A (0-24 μm). At the time indicated by the arrow (450 s), the injection phase was stopped and the cells were washed with HBS buffer. B, antigen- and receptor-binding properties of the acid conformer trapped on the type II peptide-immobilized sensor chip. Acid-treated MRA (660 nm) was trapped on the sensor chip at 2200 RU. The antigen (human IL-6R) or <t>FcγR</t> (human FcγRIa, FcγRIIb, or FcγRIIIa) was subsequently injected at each concentration (times indicated by arrows). C, schematic diagram of human IgG. Acid treatment induces conformational changes on the Fc region but not on the Fabs or antigen binding region.
Fcγr Block Clone 2.4g2, supplied by Becton Dickinson, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/fc%CE%B3r/fc%CE%B3r+block+clone+2+4g2/10__1128_slash_iai__00153___17-71-33-36
Average 90 stars, based on 1 article reviews
fcγr-block clone 2.4g2 - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

Image Search Results


The binding properties of the acid conformer to Protein A, antigen and Fcγ receptors. A, inhibition of the binding between the type II peptide and the acid conformer by Protein A. Acid-treated MRA (660 nm) was injected to the type II peptide (IMG4K6R)-immobilized sensor chip in the presence of several concentrations of Protein A (0-24 μm). At the time indicated by the arrow (450 s), the injection phase was stopped and the cells were washed with HBS buffer. B, antigen- and receptor-binding properties of the acid conformer trapped on the type II peptide-immobilized sensor chip. Acid-treated MRA (660 nm) was trapped on the sensor chip at 2200 RU. The antigen (human IL-6R) or FcγR (human FcγRIa, FcγRIIb, or FcγRIIIa) was subsequently injected at each concentration (times indicated by arrows). C, schematic diagram of human IgG. Acid treatment induces conformational changes on the Fc region but not on the Fabs or antigen binding region.

Journal:

Article Title: Discovery and Characterization of a Peptide Motif That Specifically Recognizes a Non-native Conformation of Human IgG Induced by Acidic pH Conditions * S⃞

doi: 10.1074/jbc.M807618200

Figure Lengend Snippet: The binding properties of the acid conformer to Protein A, antigen and Fcγ receptors. A, inhibition of the binding between the type II peptide and the acid conformer by Protein A. Acid-treated MRA (660 nm) was injected to the type II peptide (IMG4K6R)-immobilized sensor chip in the presence of several concentrations of Protein A (0-24 μm). At the time indicated by the arrow (450 s), the injection phase was stopped and the cells were washed with HBS buffer. B, antigen- and receptor-binding properties of the acid conformer trapped on the type II peptide-immobilized sensor chip. Acid-treated MRA (660 nm) was trapped on the sensor chip at 2200 RU. The antigen (human IL-6R) or FcγR (human FcγRIa, FcγRIIb, or FcγRIIIa) was subsequently injected at each concentration (times indicated by arrows). C, schematic diagram of human IgG. Acid treatment induces conformational changes on the Fc region but not on the Fabs or antigen binding region.

Article Snippet: Recombinant human Fcγ receptor (FcγR) Ia, IIb, and IIIa were purchased from Abnova Corporation, Taipei, Taiwan.

Techniques: Binding Assay, Inhibition, Injection, Concentration Assay